GameStop Raises eBay Stake to 6.6% as Ryan Cohen Pushes $56 Billion Takeover Bid 
Japan Airlines Signs 10-Year Boeing 787 Maintenance Deal With GE Aerospace 
JPMorgan Sees Large-Cap Biotech Stocks Entering New Growth Phase in 2026 
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme 
Google Expands AI Partnership With Singapore Government 
Texas Sues Meta Over WhatsApp Encryption Claims 
Mistral AI Acquires Emmi AI to Expand Industrial AI Solutions in Europe 
Tencent Shares Jump 4% as AI Models Move Toward Paid Commercial Services 
Lam Research Expands AI-Powered Semiconductor Tools and Arizona Operations 
X Corp Loses Legal Battle Over Australia Child Safety Fine 
Goldman Sachs to Pay $500M in 1MDB Shareholder Fraud Settlement 
Samsung Union Confirms 18-Day Strike After Failed Wage Talks 
OpenAI Eyes IPO Filing as Early as This Week Amid Rising AI Competition 
SoftBank Shares Surge as OpenAI IPO Buzz and SB Energy Filing Boost AI Optimism 
Stellantis CEO Antonio Filosa to Reveal Turnaround Strategy Focused on U.S. Sales and China Partnerships 
TrumpRx Expands Discount Drug Access With 600 Generic Medications 
H.B. Fuller Company (NYSE: FUL) has reportedly submitted a 285 pence-per-share cash offer to acquire Advanced Medical Solutions Group (LON: AMSU), intensifying takeover interest in the UK-based medical technology company. The proposed acquisition highlights growing consolidation in the healthcare and medical device sector during 2026.
The Minnesota-based adhesives manufacturer is currently conducting due diligence and holding discussions with Advanced Medical Solutions after making an unsolicited proposal on April 30, 2026. Under UK takeover regulations, H.B. Fuller must announce a firm intention to proceed with a formal bid or withdraw its interest by June 18, 2026.
According to reports, Goldman Sachs and Perella Weinberg Partners are advising H.B. Fuller on the potential transaction, while Ashurst LLP serves as legal counsel. Advanced Medical Solutions is being advised by Evercore Partners International and Investec Bank.
The possible acquisition comes shortly after private equity firm TA Associates ended its pursuit of Advanced Medical Solutions earlier this month. TA Associates had reportedly considered an offer near 280 pence per share, valuing the company at around £600 million. Before that, Montagu Private Equity also explored a potential bid but did not move forward.
Analysts believe Advanced Medical Solutions has become increasingly attractive following its 2024 acquisition of Peters Surgical, a France-based surgical products company. The deal significantly expanded AMSU’s manufacturing and sales capabilities across Europe and Asia.
The integration of Peters Surgical helped boost Advanced Medical Solutions’ 2025 revenue by 29% to £228.9 million, while adjusted EBITDA climbed 24% to £49.9 million. Industry experts suggest these stronger financial results and potential cost synergies could motivate strategic buyers like H.B. Fuller to pursue a takeover.
Despite ongoing negotiations, both companies emphasized that there is no certainty a final agreement will be reached. Investors continue monitoring developments closely as the June deadline approaches.
